All Stories

  1. Emerging Pathogens Causing Acute Hepatitis
  2. Risks and Preventions for Pregnant Women and Their Preterm Infants in a World with COVID-19: A Narrative Review
  3. The Role of Cluster of Differentiation 39 (CD39) and Purinergic Signaling Pathway in Viral Infections
  4. Cyclosporine Ameliorates Silica-Induced Autoimmune Hepatitis in Rat Model by Altering the Expression of Toll-Like Receptor-4, Interleukin-2, and Tumor Necrosis Factor-α
  5. Evaluation of Amino Acids Profile as Non-Invasive Biomarkers of Hepatocellular Carcinoma in Egyptians
  6. Motivators, Barriers, and Acceptance of COVID-19 Vaccination among Residents of Western Saudi Arabia
  7. Correlation between the severity of COVID-19 vaccine-related adverse events and the blood group of the vaccinees in Saudi Arabia: A web-based survey
  8. Is Hepatitis E Virus a Neglected or Emerging Pathogen in Egypt?
  9. Identification of promising anti-EBOV inhibitors:de novodrug design, molecular docking and molecular dynamics studies
  10. High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia
  11. A New EGFR Inhibitor from Ficus benghalensis Exerted Potential Anti-Inflammatory Activity via Akt/PI3K Pathway Inhibition
  12. The First Saudi Report of Novel and Common Mutations in the gyrA and parC Genes Among Pseudomonas Spp. Clinical Isolates Recovered from Taif Area
  13. Anti-proliferative and Apoptotic Activity Against an Acute Myeloid Leukemia Cell Line by Constituents from Ficus benghalensis
  14. Kinetic, Isotherm and Thermodynamic Aspects of Zn2+ Biosorption by Spirulina platensis: Optimization of Process Variables by Response Surface Methodology
  15. Assessment of Knowledge, Attitude, and Practice among Saudi Residents Regarding Hepatitis E Virus
  16. A study on fractional tumour–immune–vitamins model for intervention of vitamins
  17. Clinical Data Analysis for Prediction of Cardiovascular Disease Using Machine Learning Techniques
  18. Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway
  19. Health Hazards Assessment and Geochemistry of ElSibai-Abu ElTiyur Granites, Central Eastern Desert, Egypt
  20. Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 Mpro Inhibitors from Penicillium citrinum TDPEF34
  21. Role of polymeric materials in preventing COVID-19 infection
  22. Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling
  23. A Novel Vaccine Selection Decision-Making Model (VSDMM) for COVID-19
  24. Interleukin-18 and interferon-γ single nucleotide polymorphisms in Egyptian patients with tuberculosis
  25. Exploration of Knowledge, Attitude, and Practice Among Residents of Saudi Arabia Toward Hepatitis Viruses
  26. Synergistic antifungal activity of mixtures of clove, cumin and caraway essential oils and their major active components
  27. Prevalence of methicillin-resistant coagulase-negative staphylococci among Egyptian patients after surgical interventions
  28. Association of the polymorphism of the Toll‐like receptor (TLR)‐3 and TLR‐9 genes with hepatitis C virus‐specific cell‐mediated immunity outcomes among Egyptian health‐care workers
  29. Alternatively activated macrophages; a double-edged sword in allergic asthma
  30. Characterization of phenotypic and genotypic traits of carbapenem-resistant Acinetobacter baumannii clinical isolates recovered from a tertiary care hospital in Taif, Saudi Arabia
  31. Investigation of plasmid-mediated quinolone resistance in pseudomonas in Saudi Arabia
  32. Design and total synthesis of (-)-codonopsinine, (-)-codonopsine and codonopsinine analogues by O-(2-oxopyrrolidin-5-yl)trichloroacetimidate as amidoalkylating agent with improved antimicrobial activity via solid lipid nanoparticle formulations
  33. Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians
  34. High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection
  35. RNA protein kinase SNP at -226 C
  36. Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians
  37. Topical Eugenol Successfully Treats Experimental <b><i>Candida albicans</i></b>-Induced Keratitis
  38. Incidence and characteristics of hepatitis E virus infection in children in Assiut, Upper Egypt
  39. Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients
  40. Multi-drug-resistant Enterococcus faecalis among Egyptian patients with urinary tract infection
  41. Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin
  42. Molecular Typing of Methicillin Resistant Staphylococcus aureus Colonizing Egyptian Healthcare Workers and Patients
  43. Association of Interleukin-27 rs 153109 Single Nucleotide Polymorphism with Spontaneous Resolution of Hepatitis C Virus - Genotype 4a Infection in Egyptian Patients
  44. Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?
  45. Occult hepatitis C virus infection among Egyptian hemodialysis patients
  46. P-B10 Egyptian healthcare workers and Hepatitis C virus vaccines
  47. Design, Synthesis, and Molecular Docking of Novel Pyrrolooxazepinediol Derivatives with Anti-Influenza Neuraminidase Activity
  48. Is hepatitis E virus an emerging problem in industrialized countries?
  49. Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection
  50. Changing Patterns of Drug-ResistantShigellaIsolates in Egypt
  51. The emergence of hepatitis E virus in Europe
  52. Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response
  53. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians
  54. Prevalence of Methicillin Resistant Staphylococcus aureus among Egyptian Patients after Surgical Interventions
  55. Cross Reactive Cellular Immune Response to HCV Genotype 1 and 4 Antigens among Genotype 4 Exposed Subjects
  56. Increased quinolone resistance among typhoid Salmonella isolated from Egyptian patients
  57. Schistosomiasis Does Not Affect the Outcome of HCV Infection in Genotype 4-Infected Patients
  58. Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection
  59. Hepatitis C Virus-Specific Cell-Mediated Immune Responses in Children Born to Mothers Infected with Hepatitis C Virus
  60. Hepatitis B Virus Genotype D Predominates HBsAg-Positive Egyptian Blood Donors
  61. Predominant Th1 cytokines in seronegative, aviremic children who exhibit HCV-specific cell-mediated immune response
  62. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt
  63. Hepatitis C Virus-Multispecific T-Cell Responses without Viremia or Seroconversion among Egyptian Health Care Workers at High Risk of Infection
  64. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre
  65. Strong Hepatitis C Virus (HCV)–specific Cell-mediated Immune Responses in the Absence of Viremia or Antibodies Among Uninfected Siblings of HCV Chronically Infected Children
  66. Capturing and Characterizing Immune Cells from Breast Tumor Microenvironment: An Innovative Surgical Approach
  67. ‘Self-Protection’ of Individual CD4+ T Cells against R5 HIV-1 Infection by the Synthesis of Anti-Viral CCR5 Ligands
  68. Antigen stimulation induces HIV envelope gp120-specific CD4+ T cells to secrete CCR5 ligands and suppress HIV infection
  69. Characterization of hepatitis E-specific cell-mediated immune response using IFN-γ ELISPOT assay
  70. Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses
  71. Cholera Toxin Indirectly Activates Human Monocyte-Derived Dendritic Cells In Vitro through the Production of Soluble Factors, Including Prostaglandin E2 and Nitric Oxide
  72. Human β-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection
  73. EXPOSURE TO HEPATITIS C VIRUS INDUCES CELLULAR IMMUNE RESPONSES WITHOUT DETECTABLE VIREMIA OR SEROCONVERSION
  74. Pasteurella multocida Toxin Activates Human Monocyte-Derived and Murine Bone Marrow-Derived Dendritic Cells In Vitro but Suppresses Antibody Production In Vivo
  75. Recall antigen activation induces prompt release of CCR5 ligands from PBMC: implication in memory responses and immunization
  76. HIV-1 transgenic rats develop T cell abnormalities
  77. Calcium Signaling through Phospholipase C Activates Dendritic Cells To Mature and Is Necessary for the Activation and Maturation of Dendritic Cells Induced by Diverse Agonists
  78. An Enzymatically Active A Domain Is Required for Cholera-Like Enterotoxins To Induce a Long-Lived Blockade on the Induction of Oral Tolerance: New Method for Screening Mucosal Adjuvants
  79. HIV-1-suppressive factors are secreted by CD4+T cells during primary immune responses
  80. Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway
  81. Perforin-low memory CD8+cells are the predominant T cells in normal humans that synthesize the β-chemokine macrophage inflammatory protein-1β